Imprimis NJOF, LLC recalls
Imprimis NJOF, LLC is named on 10 recalls in Recall Relay's records since November 2023, from FDA (17 recalled products: FDA lists each product as its own recall); the most recent was December 18, 2025.
All 17 recalled products, newest first.
-
Class IIofficial
Imprimis NJOF, LLC recalls Dexamethasone MoxifloxacinPresence of particulate matter - Glass like particles.
-
Class IIofficial
Imprimis NJOF, LLC recalls Dexamethasone Moxifloxacin KetorolacPresence of particulate matter - Glass like particles.
-
Class IIofficial
Imprimis NJOF, LLC recalls Tri-Moxi+¿ (Triamcinolone 9mg/0.6mLPresence of particulate matter - Glass like particles.
-
Class IIIofficial
Imprimis NJOF, LLC recalls Klarity-C Drops (Cyclosporine) 0.1%Subpotent Drug
-
Class IIofficial
Imprimis NJOF, LLC recalls Epinephrine Lidocaine HCLSub-Potent Drug: Subpotent assay results during stability testing.
-
Class IIIofficial
Imprimis NJOF, LLC recalls Tropicamide-Proparacaine-Phenylephrine-KetorolacSub-Potent Drug: Subpotent assay results during stability testing.
-
Class IIIofficial
Imprimis NJOF, LLC recalls Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic SolutionSub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.
-
Class IIofficial
Imprimis NJOF, LLC recalls Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vials for Intraocular InjeLack of Assurance of Sterility
-
Class IIofficial
Imprimis NJOF, LLC recalls Klarity-C (cyclosporine) Preservative-Free Sterile Ophthalmic Emulsion 0.1% 5.5mLLack of Assurance of Sterility
-
Class IIofficial
Imprimis NJOF, LLC recalls Dexamethasone-Moxifloxacin (1 mg/mL and 5mg/mL) Preservative-FreeLack of Assurance of Sterility
-
Class IIofficial
Imprimis NJOF, LLC recalls Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vial for Intraocular InjecLack of Assurance of Sterility
-
Class IIofficial
Imprimis NJOF, LLC recalls Moxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular InjectionLack of Assurance of Sterility
-
Class IIofficial
Imprimis NJOF, LLC recalls Moxifloxacin 4 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular InjectionLack of Assurance of Sterility
-
Class IIofficial
Imprimis NJOF, LLC recalls Dexamethasone-Moxifloxacin- Ketorolac (1mg/mLLack of Assurance of Sterility
-
Class IIofficial
Imprimis NJOF, LLC recalls Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic SuspensionLack of Assurance of Sterility
-
Class IIIofficial
Imprimis NJOF, LLC recalls Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-FreeOut of specification for assay
-
Class IIofficial
Imprimis NJOF, LLC recalls Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%Subpotent Drug
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Imprimis NJOF, LLC or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts